- Home
- MDIA vs IPSC Comparison
MDIA vs IPSC Comparison
Compare MDIA & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDIA
- IPSC
- Stock Information
- Founded
- MDIA 2019
- IPSC 2019
- Country
- MDIA United States
- IPSC United States
- Employees
- MDIA N/A
- IPSC N/A
- Industry
- MDIA Broadcasting
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- MDIA Consumer Discretionary
- IPSC Health Care
- Exchange
- MDIA Nasdaq
- IPSC Nasdaq
- Market Cap
- MDIA 51.8M
- IPSC 48.2M
- IPO Year
- MDIA N/A
- IPSC 2021
- Fundamental
- Price
- MDIA $1.16
- IPSC $0.55
- Analyst Decision
- MDIA
- IPSC Strong Buy
- Analyst Count
- MDIA 0
- IPSC 5
- Target Price
- MDIA N/A
- IPSC $3.33
- AVG Volume (30 Days)
- MDIA 44.1K
- IPSC 719.1K
- Earning Date
- MDIA 05-20-2025
- IPSC 05-15-2025
- Dividend Yield
- MDIA N/A
- IPSC N/A
- EPS Growth
- MDIA N/A
- IPSC N/A
- EPS
- MDIA N/A
- IPSC N/A
- Revenue
- MDIA $116,895,000.00
- IPSC $114,898,000.00
- Revenue This Year
- MDIA N/A
- IPSC $833.10
- Revenue Next Year
- MDIA N/A
- IPSC N/A
- P/E Ratio
- MDIA N/A
- IPSC N/A
- Revenue Growth
- MDIA 268.03
- IPSC 8286.72
- 52 Week Low
- MDIA $0.79
- IPSC $0.34
- 52 Week High
- MDIA $5.73
- IPSC $3.46
- Technical
- Relative Strength Index (RSI)
- MDIA 67.84
- IPSC 47.90
- Support Level
- MDIA $0.95
- IPSC $0.53
- Resistance Level
- MDIA $1.30
- IPSC $0.59
- Average True Range (ATR)
- MDIA 0.09
- IPSC 0.04
- MACD
- MDIA 0.04
- IPSC -0.00
- Stochastic Oscillator
- MDIA 93.00
- IPSC 37.56
About MDIA Mediaco Holding Inc.
MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming, and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales, events including sponsorships and ticket sales, licensing, and syndication. The company has two business segments: the Audio segment and the Video segment. The company generates the majority of its revenue from the Audio segment.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.